UnitedHealth Group (NYSE:UNH) Stock Rating Lowered by StockNews.com

UnitedHealth Group (NYSE:UNH) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report issued on Wednesday.

Several other brokerages have also weighed in on UNH. UBS Group dropped their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Truist Financial reaffirmed a “buy” rating and set a $625.00 price objective (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Hsbc Global Res downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. KeyCorp initiated coverage on shares of UnitedHealth Group in a report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective for the company. Finally, Royal Bank of Canada reduced their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. Four research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Stock Down 2.2 %

Shares of UnitedHealth Group stock opened at $576.93 on Wednesday. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group has a 1 year low of $436.38 and a 1 year high of $630.73. The stock has a 50-day moving average price of $582.31 and a 200 day moving average price of $551.25. The company has a market cap of $530.94 billion, a P/E ratio of 37.59, a P/E/G ratio of 1.74 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm’s revenue was up 9.2% on a year-over-year basis. During the same period in the previous year, the firm posted $6.56 earnings per share. As a group, analysts expect that UnitedHealth Group will post 27.6 EPS for the current fiscal year.

Institutional Investors Weigh In On UnitedHealth Group

A number of institutional investors have recently added to or reduced their stakes in UNH. McIlrath & Eck LLC lifted its position in shares of UnitedHealth Group by 8.2% in the 3rd quarter. McIlrath & Eck LLC now owns 635 shares of the healthcare conglomerate’s stock worth $371,000 after acquiring an additional 48 shares during the period. Discipline Wealth Solutions LLC acquired a new stake in UnitedHealth Group during the third quarter worth $558,000. M&T Bank Corp lifted its holdings in shares of UnitedHealth Group by 13.4% during the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock worth $128,975,000 after acquiring an additional 26,074 shares during the period. Second Line Capital LLC increased its stake in UnitedHealth Group by 5.0% in the third quarter. Second Line Capital LLC now owns 5,037 shares of the healthcare conglomerate’s stock valued at $2,945,000 after acquiring an additional 239 shares during the period. Finally, TCW Group Inc. lifted its stake in UnitedHealth Group by 3.5% during the third quarter. TCW Group Inc. now owns 269,225 shares of the healthcare conglomerate’s stock worth $157,410,000 after purchasing an additional 8,993 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.